SUPRIYA · Health Care · 2026-08-07

Supriya Lifescience Ltd

4.5WatchEven +1.3Stage 2 · wk 9In scan: Pullback Hunter · Prop Scan · Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹923.5
+3.66% today
₹7,432 Cr · Mid cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.

Visit company website →
P/E (TTM)
35.0
Forward 26.5
Earnings Growth (YoY)
+6.0%
Revenue +11.2%
Dividend Yield
0.13%
P/B 6.0
vs 52W High
-12.3%
₹553.4 lo₹1,052.5 hi
12.3% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 9
1w13w26w
Week 9 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
22.8%
200 DMA: ₹752.2 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.37x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -2.9% vs MA50 +6.8%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
This stock ranks #18 of 79 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
→ Flat
Stage 2%
50.5%
20d Δ
+0.5pp
1M return
+1.9%
3M return
+11.7%
Industry Stage-2 % · last 20 days
Ranks #15 of 53 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-12 → 2026-08-07
S2 16w
S2 59w
S2 13w
2023-05-122026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 8w → S2 16w → S3 8w → S2 59w → S3 9w → S2 3w → S3 2w → S2 5w → S3 3w → S2 3w → S4 9w → S1 1w → S2 13w → S3 5w → S4 11w → S1 3w → S2 9w current
Total tracked: 168 weeks across 17 stage runs.
1M
+5.5%
3M
+30.7%
6M
+38.8%
YTD
+25.1%
1Y
+37.4%
Scan Membership
Pullback Hunter
Latest: 2026-07-14
Prop Scan
Latest: 2026-07-14
Breakout Watch
Latest: 2026-06-08
35 appearances in last 60 days. First seen: 2025-04-16.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S2
Wk 9 · Vol —x
2026-08-06S2
Wk 9 · Vol —x
2026-08-05S2
Wk 9 · Vol —x
2026-08-04S2
Wk 9 · Vol —x
2026-08-03S2
Wk 8 · Vol —x
2026-07-31S2
Wk 8 · Vol —x
2026-07-30S2
Wk 8 · Vol —x
2026-07-29S2
Wk 8 · Vol —x
2026-07-28S2
Wk 8 · Vol —x
2026-07-27S2
Wk 7 · Vol —x
2026-07-24S2
Wk 7 · Vol —x
2026-07-23S2
Wk 7 · Vol —x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹908.6
200 DMA
₹752.2
52W High
₹1,052.5
52W Low
₹553.4
5D Low
₹879.7
Resistance levels (recent highs)
20d High
₹923.5
60d High
₹1,052.5
120d High
₹1,052.5
250d High
₹1,052.5
Next resistance
+14.0%
to 60d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.